BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33633683)

  • 1. Evaluation of Ultrasound-Guided Radiofrequency Ablation as a Treatment Option for Papillary Thyroid Microcarcinoma in the Isthmus: A Retrospective Study.
    Song Q; Gao H; Tian X; Ren L; Lan Y; Yan L; Luo Y
    Front Endocrinol (Lausanne); 2020; 11():599471. PubMed ID: 33633683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Treating Low-Risk Papillary Thyroid Microcarcinoma: A Prospective Study.
    Zhang M; Luo Y; Zhang Y; Tang J
    Thyroid; 2016 Nov; 26(11):1581-1587. PubMed ID: 27445090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
    Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
    Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
    [No Abstract]   [Full Text] [Related]  

  • 4. The Efficacy and Safety of Radiofrequency Ablation for Bilateral Papillary Thyroid Microcarcinoma.
    Yan L; Zhang M; Song Q; Xiao J; Zhang Y; Luo Y
    Front Endocrinol (Lausanne); 2021; 12():663636. PubMed ID: 34177804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma.
    Ding M; Tang X; Cui D; Chi J; Shi Y; Wang T; Zhai B; Li P
    Clin Radiol; 2019 Sep; 74(9):712-717. PubMed ID: 31253420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients.
    Yan L; Lan Y; Xiao J; Lin L; Jiang B; Luo Y
    Eur Radiol; 2021 Feb; 31(2):685-694. PubMed ID: 32813103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a systematic review and meta-analysis.
    Xue J; Teng D; Wang H
    Int J Hyperthermia; 2022; 39(1):1300-1309. PubMed ID: 36195326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a retrospective analysis of 198 patients.
    Wu R; Luo Y; Tang J; Yang M; Li J; Zhang Y; Zhang M
    Int J Hyperthermia; 2020; 37(1):168-174. PubMed ID: 32026736
    [No Abstract]   [Full Text] [Related]  

  • 9. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.
    Chung SR; Baek JH; Choi YJ; Lee JH
    Eur Radiol; 2019 Sep; 29(9):4897-4903. PubMed ID: 30805701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study.
    Yan L; Zhang M; Song Q; Xie F; Luo Y
    Eur Radiol; 2022 Feb; 32(2):1216-1226. PubMed ID: 34357450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One year follow-up of US-Guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: The first experience in Taiwan.
    Lim LS; Lin WC; Chiang PL; Huang SC; Chen YS; Chang YH; Chen WC; Chi SY; Chou CK
    J Formos Med Assoc; 2022 Aug; 121(8):1406-1413. PubMed ID: 34657768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up.
    Zhang M; Tufano RP; Russell JO; Zhang Y; Zhang Y; Qiao Z; Luo Y
    Thyroid; 2020 Mar; 30(3):408-417. PubMed ID: 31910107
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-Term Efficacy of Ultrasound-Guided Percutaneous Laser Ablation for Low-Risk Papillary Thyroid Microcarcinoma: A 5-Year Follow-Up Study.
    Peng K; Zhou P; Liu W
    Biomed Res Int; 2021; 2021():6616826. PubMed ID: 34337037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
    Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
    Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic Evolution and Pathologic Findings of Papillary Thyroid Cancer After Radiofrequency Ablation: A Five-Year Retrospective Cohort Study.
    Li X; Li Y; Yan L; Xiao J; Yang Z; Jing H; Zhang M; Luo Y
    Thyroid; 2024 Jan; 34(1):54-63. PubMed ID: 37885207
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-Analysis of the Application Effect of Different Modalities of Thermal Ablation and Surgical Treatment in Papillary Thyroid Microcarcinoma.
    Li T; Lu B; Zhang Y; Sun Y
    Dis Markers; 2022; 2022():9714140. PubMed ID: 36217504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life in Papillary Thyroid Microcarcinoma Patients Undergoing Radiofrequency Ablation or Surgery: A Comparative Study.
    Lan Y; Luo Y; Zhang M; Jin Z; Xiao J; Yan L; Zhu Y
    Front Endocrinol (Lausanne); 2020; 11():249. PubMed ID: 32499754
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.
    Yan L; Zhang M; Song Q; Luo Y
    Thyroid; 2021 Nov; 31(11):1662-1672. PubMed ID: 34269611
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
    Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma.
    Yang Z; Yan L; Xiao J; Li W; Li X; Li Y; Zhang M; Luo Y
    Int J Hyperthermia; 2023; 40(1):2191912. PubMed ID: 37164353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.